- Home
- EBMT vs TLSI Comparison
EBMT vs TLSI Comparison
Compare EBMT & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBMT
- TLSI
- Stock Information
- Founded
- EBMT 1922
- TLSI 2010
- Country
- EBMT United States
- TLSI United States
- Employees
- EBMT N/A
- TLSI N/A
- Industry
- EBMT Major Banks
- TLSI Medical Specialities
- Sector
- EBMT Finance
- TLSI Health Care
- Exchange
- EBMT Nasdaq
- TLSI Nasdaq
- Market Cap
- EBMT 136.9M
- TLSI 150.0M
- IPO Year
- EBMT N/A
- TLSI N/A
- Fundamental
- Price
- EBMT $17.32
- TLSI $4.89
- Analyst Decision
- EBMT
- TLSI Strong Buy
- Analyst Count
- EBMT 0
- TLSI 5
- Target Price
- EBMT N/A
- TLSI $10.90
- AVG Volume (30 Days)
- EBMT 21.8K
- TLSI 109.8K
- Earning Date
- EBMT 10-28-2025
- TLSI 08-12-2025
- Dividend Yield
- EBMT 3.30%
- TLSI N/A
- EPS Growth
- EBMT 49.06
- TLSI N/A
- EPS
- EBMT 1.61
- TLSI N/A
- Revenue
- EBMT $84,696,000.00
- TLSI $35,990,000.00
- Revenue This Year
- EBMT N/A
- TLSI $56.79
- Revenue Next Year
- EBMT $5.20
- TLSI $54.15
- P/E Ratio
- EBMT $10.91
- TLSI N/A
- Revenue Growth
- EBMT 5.13
- TLSI 45.50
- 52 Week Low
- EBMT $14.35
- TLSI $3.42
- 52 Week High
- EBMT $18.49
- TLSI $5.88
- Technical
- Relative Strength Index (RSI)
- EBMT 56.12
- TLSI 51.95
- Support Level
- EBMT $17.19
- TLSI $4.80
- Resistance Level
- EBMT $17.99
- TLSI $5.24
- Average True Range (ATR)
- EBMT 0.29
- TLSI 0.31
- MACD
- EBMT 0.02
- TLSI 0.00
- Stochastic Oscillator
- EBMT 48.06
- TLSI 49.26
About EBMT Eagle Bancorp Montana Inc.
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.